EUVIMEDEUVIMED entdecken
Crossref

The Outcome of Intra Articular Ketorolac vs Corticosteroid Injection in Symptomatic Knee Osteoarthritis

Devish Sadatiya, Sumit Batra, Himanshu Mer

International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Devish Sadatiya und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intra-articular (IA) therapy is widely used for symptomatic knee osteoarthritis (OA) when oral medications are inadequate or poorly tolerated. This randomized controlled study compared the efficacy of IA ketorolac versus methylprednisolone acetate in relieving pain and improving function in patients with symptomatic knee OA.

Methods

One hundred and twelve adults with clinically and radiographically confirmed knee OA were randomized to receive a single IA injection of either ketorolac (30 mg with lignocaine) or methylprednisolone acetate (80 mg with lignocaine). Pain was assessed using the Visual Analogue Scale (VAS) and function using the Oxford Knee Score (OKS) at baseline, 4 weeks and 12 weeks.

Results

Baseline characteristics and scores were comparable between groups. Mean VAS decreased from 7.0 to 5.3 and 4.7 at 4 and 12 weeks in the ketorolac group, and from 7.2 to 3.5 and 1.6 in the corticosteroid group. Between-group analysis showed significantly lower VAS with corticosteroid at 4 weeks (mean difference 1.8, p < 0.01) and 12 weeks (mean difference 3.1, p < 0.01). OKS improved significantly in both groups, with consistently superior gains in the corticosteroid arm.

Conclusions

Both IA ketorolac and methylprednisolone improved symptoms, but corticosteroid produced greater and more sustained pain relief and functional benefit.

Zitieren

APA

Sadatiya, D., Batra, S., & Mer, H. (2026). The Outcome of Intra Articular Ketorolac vs Corticosteroid Injection in Symptomatic Knee Osteoarthritis. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.231

Vancouver

Sadatiya D, Batra S, Mer H. The Outcome of Intra Articular Ketorolac vs Corticosteroid Injection in Symptomatic Knee Osteoarthritis. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.231

BibTeX
@article{Sadatiya2026,
  author = {Sadatiya, Devish and Batra, Sumit and Mer, Himanshu},
  title = {The Outcome of Intra Articular Ketorolac vs Corticosteroid Injection in Symptomatic Knee Osteoarthritis},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.231}
}
Kostenlos starten →